IP Library Granted Patent US 9,789,225
Granted Patent B2
US 9,789,225 · App. 14/933,217 · Granted Oct 17, 2017

Shapeable bone graft substitute and instruments for delivery thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,789,225
App. No.
14/933,217
Granted
Oct 17, 2017
Kind
B2
Abstract

Injectable bone graft material having a biocompatible, resorbable polymer and a biocompatible, resorbable inorganic material exhibiting macro, meso, and microporosities.

Claims (19)

1. A flowable body having macro-porosity, meso-porosity, and microporosity comprising:

a homogenous mixture comprising a biocompatible polymer in the amount of about 15% to about 30% by weight and

a material with a size range of about 100 μm to about 4000 μm comprising the oxidation-reduction reaction product of at least one metal cation, at least one oxidizing agent, and at least one oxidizable precursor anion, wherein the reaction product comprises calcium phosphate: said flowable body being imbibed with a fluid, and

wherein homogeneous means that the porosity and pore size distribution is the same throughout the composite.

2. The flowable body of claim 1 having a porosity of about 75%.

3. The flowable body of claim 1 having a porosity of about 80%.

4. The flowable body of claim 1 having a porosity of about 90%.

5. The flowable body of claim 1 , wherein said polymer comprises collagen.

6. The flowable body of claim 1 , wherein said polymer comprises soluble collagen.

7. The flowable body of claim 6 , wherein said soluble collagen has limited cross-links.

8. The flowable body of claim 1 comprising about 15% to about 25% by weight of biocompatible polymer.

9. The flowable body of claim 1 comprising about 15% to about 20% by weight of biocompatible polymer.

10. The flowable body of claim 1 comprising about 20% to about 30% by weight of biocompatible polymer.

11. The flowable body of claim 1 , wherein said fluid is saline, bone marrow aspirate, or blood.

12. The flowable body of claim 1 , wherein said fluid further comprises antibiotics, bone morphogenic proteins, or a therapeutic agent.

13. The flowable body of claim 1 , wherein said reaction product comprises beta tri-calcium phosphate.

14. The flowable body of claim 1 , wherein said calcium phosphate has a size range of about 250 μm to about 2000 μm.

15. The flowable body of claim 1 , wherein said calcium phosphate has a size range of about 250 μm to about 1000 μm.

16. The flowable body of claim 1 , wherein the flowable body has a porosity of at least 70% and wherein about 50% to about 60% of said porosity is macroporosity, about 15% to about 40% of said porosity is mesoporosity, and about 10% to about 15% of said porosity is microporosity.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2023
From: ORTHOVITA, INC.
To: STRYKER CORPORATION
Reel/Frame 065735/0360 →
MERGER Recorded Nov 24, 2015
From: VITA LICENSING, INC.; PARTISYN CORP.
To: ORTHOVITA, INC.
Reel/Frame 037132/0151 →
MERGER Recorded Nov 23, 2015
From: VITA SPECIAL PURPOSE CORPORATION
To: VITA LICENSING, INC.
Reel/Frame 037152/0987 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2015
From: BAGGA, CHARANPREET S.; CLINEFF, THEODORE D.; ERBE, ERIK M.; PARIS, MICHAEL W.; NAGVAJARA, GINA M.; KOBLISH, ANTONY
To: VITA SPECIAL PURPOSE CORPORATION
Reel/Frame 037100/0882 →